Delsia

Autism Speaks Hosts World’s First Autism Investment Conference

On February 21st, investors and product developers came together to discuss opportunities for addressing the autism community’s unmet needs

... More...

Arbaclofen Shows Promise for Treating Core Symptoms of Autism

Compound advances into larger clinical trials; could pave the way for other future medicines as well

... More...

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to ... More...

Contact Us

Address 1060 State Road Princeton, NJ 08540 USA 609-228-7337 Fax 609-430-9505 General information (contactus@delsia.org) Press/media inquir... More...

Press

Delsia press page

... More...

Frequently asked questions (FAQs)

What is the source of DELSIA’s funding? DELSIA operates exclusively on financial support provided through investments from Autism Speaks. Supplemental grants may also be approved to DELSIA by the Autism Speaks Board of Direc... More...

Our Funding Approach

Who do we work with? DELSIA works with partners in the for-profit sector to fund development activities that are best positioned to deliver products aligned with the diverse unmet medical and behavioral health needs of the autism ... More...

Syndicate content